Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1498273A details microbial reduction for chiral alcohols. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN107382644A reveals a Pd-catalyzed route for high-purity chiral tertiary alcohols. Discover cost reduction in chiral drug manufacturing and supply advantages.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN108192932B details a mild enzymatic route for chiral alcohols, offering high ee values and scalable production for pharmaceutical intermediates.
Patent CN113087691A details a Pd-catalyzed kinetic resolution for chiral aryl tertiary alcohols. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN106497996B reveals a high-ee enzymatic route for chiral alcohols. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN112852894A reveals SpAmDH mutant for high-purity chiral amino alcohol. Enables cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN105316250B reveals Empedobacter brevis ZJUY-1401 for high-purity chiral alcohol synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110592035B reveals high-efficiency carbonyl reductase mutants for chiral alcohol production, offering significant supply chain and cost advantages.
Patent CN112481226A discloses solvent-tolerant ADH mutants enabling 99.9% conversion for chiral diaryl alcohols, offering a green alternative to costly chemical synthesis.
Patent CN105316250A reveals Empedobacter brevis strain for high-purity chiral alcohols. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN103214344B reveals efficient alkyne conversion. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103642849A details a high-yield Geotrichum candidum reduction method for chiral intermediates, offering significant cost and supply chain advantages.
Patent CN100554403C reveals Microbacterium oxydans for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN110257351A reveals high-activity enzyme mutants for chiral alcohol synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN116179502A details a novel ketoreductase mutant enabling >99% ee chiral alcohol synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN115108875A reveals a metal-free visible light asymmetric method for synthesizing nitrogen-containing chiral cyclic alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107382644B details a novel Pd-B co-catalyzed asymmetric method for chiral tertiary alcohols, offering high ee and mild conditions for antifungal drug manufacturing.